Lars Stubberud

This profile gathers the share dealings of Lars Stubberud in Calliditas Therapeutics AB. In total, 3 filings cover trades dated from 1 July 2024 to 2 July 2024.

Market trades split into 1 purchase and 2 sales (€220k). No amount is published for 1 filing, which the totals therefore leave out. Unlike grants, an open-market purchase is paid for by the insider, at the market price.

The newest entry dates from 4 July 2024: an open-market purchase, in Calliditas Therapeutics AB. Between a trade and the moment it shows up on Finansinspektionen, the median delay is 3 days. For comparison, MAR article 19 gives managers three business days to notify a trade. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. Every figure here comes from the filings published by Finansinspektionen and describes the past, not future prices; it is not investment advice.